4.7 Review

Renal replacement therapy in acute kidney injury: controversy and consensus

期刊

CRITICAL CARE
卷 19, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s13054-015-0850-8

关键词

-

资金

  1. Gambro (a brand of Baxter, Deerfield, IL, USA)
  2. Fresenius (Bad Homburg, Germany)
  3. Frenenius
  4. Gambro

向作者/读者索取更多资源

Renal replacement therapies (RRTs) represent a cornerstone in the management of severe acute kidney injury. This area of intensive care and nephrology has undergone significant improvement and evolution in recent years. Continuous RRTs have been a major focus of new technological and treatment strategies. RRT is being used increasingly in the intensive care unit, not only for renal indications but also for other organ-supportive strategies. Several aspects related to RRT are now well established, but others remain controversial. In this review, we review the available RRT modalities, covering technical and clinical aspects. We discuss several controversial issues, provide some practical recommendations, and where possible suggest a research agenda for the future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据